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Abstract—Adoption of Virtual Reality (VR), Augmented Re-
ality (AR) and Mixed Reality (MR) - known collectively as
Extended Reality (XR) devices has been rapidly increasing over
recent years. However, the focus of XR research has shown a lack
of diversity in solutions to the problems within medicine, with it
being predominantly focused in augmenting surgical procedures.
Whilst important, XR applied to aiding medical diagnosis and
surgical planning is relatively unexplored. In this paper we
present a fully functional mammographic image analysis system,
Breast3D, that can reconstruct MRI and CT scan data in XR.
With breast cancer Breast Imaging-Reporting and Data System
(BI-RADS) risk laxicon, early detection and clinical workflow
such as Multi-disciplinary team (MDT) meetings for cancer in
mind, our new mammography visualization system reconstructs
CT and MRI volumes in a real 3D space. Breast3D is built
upon the past literature, and inspired from research for diagnosis
and surgical planning. In addition to visualising the models in
MR using the Microsoft HoloLens, Breast3D is versatile and
portable to different XR head-mounted displays such as HTC
Vive. Breast3D demonstrates the early potential for XR within
diagnostics of 3D mammographic modalities, an application that
has been proposed but until now has not been implemented.
Index Terms—Extended Reality, Mixed Reality, Augmented
Reality, Breast Cancer, Computer Aided Diagnosis
I. INTRODUCTION
Diagnostic radiology constitutes the largest pool of medical
images in clinical practice. A large community of image
processing experts, medical physicists, and computer vision
experts develop methods and algorithms aiming to help clini-
cians at the point of care. Magnetic resonance imaging (MRI)
is used to get an in-depth analysis of potential abnormali-
ties in breasts. It evidently overcomes the limitations of a
conventional mammogram, particularly in finding tumours in
dense breasts. MRI builds 3D reconstructed stack of images
that can be zoomed in and out while projected on a 2D
’flat’ screen. However, the intrinsic value of 3D data in a 2D
representation poses a fundamental challenge and investigation
gap in exploiting its full clinical and research potential.
Breast cancer screening is routine clinical practice in the
UK (and several other countries around the world) for post-
menopause and high-risk women. It has proved vital in re-
ducing the mortality rate via early detection and diagnosis
of breast cancer, and in prognosis for increasing the life
expectancy. It is estimated that without screening in early
detection, there would be 360.1 years of life lost per 1,000
women [1]. With early diagnosis patients have a improved
prognosis, reducing the overall cost of the treatment, and
widening the available treatments. A system to aid the screen-
ing process in the diagnosis of breast cancer has been proposed
for XR [2], however, its potential applicability within clinical
settings are yet to be investigated.
Early validation of extended reality (XR) devices have
helped grow its research within the medical sector. But there
is great potential still in developing the fundamental tech-
niques in XR to aid radiologists in diagnosis. With XR’s
ability to interact and anchor 3D objects within the real-world
these technologies are suited to these problems. Whilst other
approaches to 3D visualisation have been presented, few of
them like XR address the challenges faced by radiologist in
providing a practical and ergonomic solution.
II. EXTENDED REALITY IN BREAST IMAGE ANALYSIS
XR is in the early years of its applications to breast image
analysis. It’s potential has started to be identified for radiology
in the past few years [3], and some have began to investigate
the applicability [4] with utilising this technology in radiology
and oncology. Most of the work in the area in general is within
surgical planning, nevertheless, specifically for breast cancer
using MRI data. However, there are even fewer examples of
XR in breast cancer radiology [5].
As previously mentioned there are few proof-of-concept
AR systems within mammography. XR technology has yet to
reach its full potential for radiology, preliminary systems have
started to be proposed for breast cancer diagnosis. The system
D3D [5]–[7] is the only known XR system for breast cancer
diagnosis. D3D showed promising results demonstrating the
depth perception and focal point convergence of XR systems in
medical imaging. They noted in their findings that they are yet
to determine the utility of the system with the clinical practice.
In addition, they are yet to demonstrate the improvement upon
the visualisation of XR over 2D representations. The system
achieves basic volumetric rendering, with an interaction sys-
tem of movements using a joystick. Whilst functional, we
believe this is challenging to implement in a clinical setting in
its current form, as compared to ’controlerless’ environments
[4], [8].
Our paper proposes an XR system, Breast 3D, for use in
mammography. It improves upon the current practice as well
as extend to other radiological and oncological sub specialities.
We show with our system we are able to produce an apparatus
for visualising and interacting with radiological data using
Microsoft Hololens. The application we propose has much
further potential for distributed systems. We present a few
application where Breast 3D could be useful for breast cancer
image analysis in future.
A. XR Radiomics
The potential impact of XR on radiology is discussed in
[3], [4] and [5]. However, there is greater potential in the
applicability of XR in breast and medical image analysis that
has yet to by exploited. Breast screening as proven by [1] helps
in the early detection of breast cancer. A significant practice
within breast cancer screening is assessment of breast cancer
risk. It is found that within the years 2018-2019 in the UK, 8.8
cases of breast cancer were found per 1000 women screened
in this process. XR visualisation of data will open doors for
extracting new radiomic features using data-characterisation
algorithms, that are otherwise hard to see using a naked eye.
B. Breast Cancer Risk Assessment
XR systems offer potential to redefine approaches to
quantify breast density classification, commonly the breast
imaging-reporting and data system (BI-RADS) [9]. BI-RADS
categorises patients into four risk categories A, B, C and
D from breast predominantly fatty to extremely dense. BI-
RADS correlate with the risk of a patient developing breast
cancer, for example [10] in women aged 60-74, a patient
has relative risk of 1.42 in BI-RADS, meaning they are 42%
more likely to develop breast cancer when compared to the
average risk of that age group. When comparing women aged
50-59 [10] finds that women are 2.1 times higher at risk of
developing breast cancer having been assessed as BI-RADS D
as compared to BI-RADS A. The leading software for breast
density assessment are Volpara [11] and Quantra [12]. To our
knowledge there is no system that uses volumetric data from
XR to quantify breast density into fat and non-fat.
C. Cancer Masking
Higher BI-RADS score pose a high risk of developing breast
cancer. However, commonly seen within patients of BI-RADS
C and D, a developing mass could be masked. Breast tissue can
be comprised of complex patterns of focal densities, resulted
from multi-layered and multi-oriented tissue composition [13].
This has a sever impact in detection masses hiding behind a
dense parenchyma, particularly in dense breasts [14] where
human perception fail to penetrate through focal densities. It is
estimated that 20% of invasive breast cancers are missed [15],
which are later detected as interval cancers. XR can provide
a better approach to visualisation and volume exploration
of 3D mammographic CT and MRI volumes. With an XR
system, masses can be unmasked as the user can view from
all angles. In cases where dense tissue obscures the mask a
different viewing angle may be used to confirm developing
asymmetries. In addition, by giving the user a better method
Fig. 1: Annotation of a point of interest (POI) with position
and clinical notes
of volume exploration within XR freely controlled using hands
gestures. Breast 3D will enable radiologists to be able navigate
through the volume, slicing and segmenting regions from all
angles to better understand breast composition.
III. DIAGNOSTIC TOOLS IN XR
Our System, Breast3D, can be broken down into four core
functionalities. These are 1) Voice commands; 2) Volume
Interaction; 3) Volume Exploration; 4) Annotation. We will
briefly explain these here.
A. Voice Commands
The most novel feature in comparison to other artefacts
in literature is that Breast3D incorporates voice commands
(a feature offered in Microsoft HoloLens but may not be
supported by other manufacturers) to automate volume ex-
ploration. Currently our model offers the following voice
command interactions with the reconstructed volume:
• Posterior - Orientates the volume to focus on the posterior
region of the breast
• Anterior - Orientates the volume to focus on the anterior
region of the breast
• Superior - Orientates the volume to focus on the superior
region of the breast
• Inferior - Orientates the volume to focus on the inferior
region of the breast
• Left - Orientates the volume to focus on the left region
of the breast
• Right - Orientates the volume to focus on the right region
of the breast
Fig. 2: User performing a pinch gesture of the hand to rotate
a MRI breast volume in XR
• Annotate - Spawns a annotation within the volume
B. Data Annotation
Breast3D can accurately get the position of data points
within the volume in x, y and z axes to report an absolute point
rather than relative description used in clinical reports. This
point can be on the surface of the reconstructed model or deep
embedded inside the stack accessed via our UI shown in figure
1. This provide the basis for further building a framework that
is able to capture, save and share clinical observations for
mammography.
C. Volume Interaction
Current systems used to examine radiological and oncolog-
ical data implements various forms of user interfaces (UI) for
CT/MRI volume exploration. This is typically performed by
the use of traditional methods relying on computer peripherals,
i.e. a keyboard and mouse in conjunction with a 2D screens.
XR does not just differentiate between a 3D to 2D visualisa-
tion, as it allows for previously unavailable ways of interaction
by replacing the controller with hand gestures, replacing the
need for a keyboard and mouse. Breast3D utilises a 3D UI
which is fed and controlled by spatial motion data produced
as a result of hand tracking. Research has shown that 3D UIs
can enhance user understanding of clinical data [16], thus
offering an more efficient interactive experience. Moreover,
Breast3D can be expanded for use by multiple users at the
same time, where various clinicians in the same and diverse
locations can interact with the same volume at the same time.
Hand gestures allows for key interactions within the volume.
These includes the movement of the reconstructed volume in
real space; scaling in size; rotation; colourization; zooming in
and out as well as traversing through volume from all angles.
The most significant feature of all is the ability to annotate a
contradicted model in real space using a finger tip.
D. Volume Exploration
We have designed 3D UI shown in figure 3 for axis-aligned
slicing, where the slicing plane is aligned to a specific axis.
Fig. 3: 3D user interface in extended reality
We have used Microsoft mixed reality toolkit (MRTK) for our
design, a publicly available library for building augmented
reality applications. This allows for operations that would
enable radiologists to explore the volume in a 3D real space;
however, consistent with the UIs used in 2D clinical explorers.
Users can control the reconstructed volume with hand gestures.
The system uses bar sliders to enable search for unmasking
(and potentially outlining) of ROI’s, by traversing through the
stack of the volume across x, y and z axes. We demonstrate
an example of exploration in figure 4, where the interaction
elements discussed of Breast3D can be used together to isolate
an ROI. First the breast MRI shown in figure 4a is rotated to
the superior view shown in figure 4b, this can be done by
the process shown in figure 2 by using pinch gesture or by
utilising voice commands. Next utilising the 3D UI shown in
figure 3, the right breast can be isolated by axis aligned slicing
by moving the sliders, the result of this is shown in figure 4c.
We further enhanced this by zooming in and pinching with
both hands to move them apart.
IV. DISCUSSION
We have highlighted XR’s specific use cases in medical
image analysis of breast data, including its use for 3D visuali-
sation, XR distributed radiology such as for multi-disciplinary
team meetings, and specimen co-registration as shown by [4].
In addition, we have discussed the vast advantages of XR
and how the technology improves upon the current practice
in interactivity and visualisation. Furthermore the XR system
extends to other radiological and oncological sub specialities.
We discussed in detail the key functionalities XR systems
provide and the advantages they offer over current practices
within breast image analysis for mammography. We presented
the potential improvements on current methods that can be
made in visualisation, risk assessment and the unmasking of
obscured masses when applying XR in breast radiomics.
Future research will apply existing image analysis tech-
niques and develop new methods within XR, with the aim to
specifically aid clinicians in diagnosis of breast cancer. This
comprises of the further development of a interactive system to
(a) Full view of breast MRI from
inferior position of the BI-RADS-
6 scan
(b) Full view of breast MRI from
the superior with adjustment to
intensity values
(c) View from the superior of the
right breast after isolation by axis-
aligned slicing
(d) View from the superior of the
right breast after isolation by axis-
aligned slicing
Fig. 4: Isolation of a tumour of a BI-RADS 6 (biopsy proven
mass) using Breast3D’s interaction techniques
aid clinicians to overcome issues faced in mammography such
as cancer masking, catching interval cancers earlier and finding
developing focal asymmetries. Further development Breast3D
will continue for its evaluation in a clinical setup. Adaptions
can be made to convert Breast3D into a distributed system
which is versatile for suitable for MDT meetings. Utilising our
developed XR system we aim to quantify breast density with
3D volumetric data as opposed to current methods with 2D
mammography. This will be done by differentiating between
fat and non-fat component of the breast paranchyma and
finding its percentage over the read 3D volume of the breast.
The accumulation of this aims to overcome the weaknesses of
using only 2D data to classify into BI-RADS when assessing
breast cancer risk.
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